Beximco Pharmaceuticals Limited (BXP.L)
GBp 36.5
(0.0%)
GBp 36.5
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 6.08 Billion | 5.49 Billion | 6.02 Billion | 5.54 Billion | 2.95 Billion | 1.81 Billion |
| Net Income | 4.52 Billion | 5.12 Billion | 5.12 Billion | 3.51 Billion | 3.03 Billion | 2.53 Billion |
| Depreciation & Amortization | 2.06 Billion | 370.23 Million | 1.11 Billion | 1.11 Billion | 942.76 Million | 845.9 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -734.16 Million | -1.9 Billion | -652.68 Million | -40.63 Million | -1.5 Billion | -1.68 Billion |
| Other non-cash items | 233.98 Million | 1.9 Billion | 434.06 Million | 954.47 Million | 484.6 Million | 127.09 Million |
| Investing Cash Flow | -2.61 Billion | -7.68 Billion | -2.52 Billion | -1.94 Billion | -4.51 Billion | -6.62 Billion |
| Investments in PPE | -2.71 Billion | -2.93 Billion | -2.55 Billion | -2.27 Billion | -4.54 Billion | -5.05 Billion |
| Acquisitions | - | -4.76 Billion | - | - | - | -2.12 Billion |
| Investment purchases | - | - | - | - | - | 106.92 Million |
| Sales/Maturities of investments | - | - | - | 323.36 Million | 16.03 Million | 547.17 Million |
| Other Investing Activities | 93.01 Million | 26.07 Million | 33.77 Million | 5.07 Million | 19.03 Million | -91.3 Million |
| Financing Cash Flow | -3.56 Billion | 2.61 Billion | -3.45 Billion | -3.57 Billion | 1.76 Billion | 4.9 Billion |
| Debt repayment | -1.76 Billion | -2.73 Billion | -504.63 Million | -1 Billion | -1.41 Billion | -1.85 Billion |
| Dividends payments | -1.56 Billion | -1.62 Billion | -578.35 Million | -601.95 Million | -505.35 Million | -502.75 Million |
| Common Stock Repurchased | - | - | - | - | 1.41 Billion | - |
| Common Stock Issuance | - | - | - | - | 100.00 | - |
| Other Financing Activities | -229.38 Million | 4.23 Billion | -2.37 Billion | -1.97 Billion | 2.27 Billion | 5.4 Billion |
| Accounts receivables | -431.83 Million | 352.25 Million | 431.6 Million | 29.5 Million | -573.44 Million | -566.04 Million |
| Accounts payables | 431.83 Million | -352.25 Million | 146.06 Million | -72.98 Million | 43.65 Million | - |
| Inventory | -1.82 Billion | -2.56 Billion | -1.08 Billion | -70.13 Million | -927.4 Million | -1.21 Billion |
| Other working capital | 1.09 Billion | 655.63 Million | -146.06 Million | 72.98 Million | -43.65 Million | -475.84 Million |
| Cash at beginning of period | 1.16 Billion | 973.96 Million | 635.01 Million | 610.49 Million | 393.73 Million | 292.12 Million |
| Cash at end of period | 1.13 Billion | 1.16 Billion | 675.46 Million | 635.01 Million | 610.49 Million | 393.73 Million |
| Capital Expenditure | -2.71 Billion | -2.93 Billion | -2.55 Billion | -2.27 Billion | -4.54 Billion | -5.05 Billion |
| Effect of forex changes on cash | 59.81 Million | 45.36 Million | - | 1.96 Million | 215.61 Thousand | - |
| Net cash flow / Change in cash | -32.98 Million | 194.71 Million | 40.45 Million | 24.52 Million | 216.75 Million | 101.61 Million |
| Free Cash Flow | 3.37 Billion | 2.55 Billion | 3.46 Billion | 3.26 Billion | -1.58 Billion | -3.23 Billion |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.36 Billion | 1.43 Billion | 1.55 Billion | 4.52 Billion | 979.47 Million | 950.56 Million |
| Depreciation & Amortization | -984.89 Million | 491.71 Million | 493.17 Million | 2.06 Billion | 316.99 Million | 523.46 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 743.32 Million | -939.07 Million | 195.75 Million | -734.16 Million | -56.84 Million | 269.78 Million |
| Other non-cash items | 1 Billion | 773.22 Million | 466.51 Million | 233.98 Million | 534.55 Million | -793.24 Million |
| Investing Cash Flow | -344.36 Million | -599.98 Million | -807.31 Million | -2.61 Billion | -831.32 Million | -474.56 Million |
| Investments in PPE | -415.81 Million | -470.46 Million | -513.15 Million | -2.71 Billion | -832.7 Million | -501.06 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 44.79 Million | -129.51 Million | -294.15 Million | 93.01 Million | 1.37 Million | 26.49 Million |
| Financing Cash Flow | -1.72 Billion | -1 Billion | -2.1 Billion | -3.56 Billion | -829.38 Million | -1.72 Billion |
| Debt repayment | -154.98 Million | -503.29 Million | -211.31 Million | -1.76 Billion | -504.86 Million | -207.33 Million |
| Dividends payments | -1.56 Billion | -896 Thousand | -231 Thousand | -1.56 Billion | -14.45 Million | -1.55 Billion |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 41.12 Million | -504.02 Million | -1.88 Billion | -229.38 Million | -310.07 Million | 33.71 Million |
| Accounts receivables | 132.66 Million | -36.09 Million | -96.56 Million | -431.83 Million | -448.81 Million | 172.72 Million |
| Accounts payables | - | - | - | 431.83 Million | -276.49 Million | 41.46 Million |
| Inventory | 441.74 Million | -548.04 Million | 106.3 Million | -1.82 Billion | 391.96 Million | 97.06 Million |
| Other working capital | 168.91 Million | -354.93 Million | 186.01 Million | 1.09 Billion | 276.49 Million | -41.46 Million |
| Cash at beginning of period | 1.09 Billion | 943.87 Million | 1.13 Billion | 1.16 Billion | 983.8 Million | 1.24 Billion |
| Cash at end of period | 1.16 Billion | 1.09 Billion | 943.87 Million | 1.13 Billion | 1.13 Billion | 983.8 Million |
| Capital Expenditure | -415.81 Million | -470.46 Million | -513.15 Million | -2.71 Billion | -832.7 Million | -501.06 Million |
| Effect of forex changes on cash | 18 Thousand | 786 Thousand | 7.15 Million | 59.81 Million | 38.42 Million | 3.65 Million |
| Net cash flow / Change in cash | 64.61 Million | 151.93 Million | -191.8 Million | -32.98 Million | 151.88 Million | -262.72 Million |
| Free Cash Flow | 1.71 Billion | 1.28 Billion | 2.19 Billion | 3.37 Billion | 941.46 Million | 449.5 Million |
601116
BPAQF
COSM
2208
FBK
VSSYW